What interactions does Cosentyx (secukinumab) have?
Cosentyx (secukinumab) is an antibody that blocks interleukin-17A (IL-17A). Because it does not act as a typical small-molecule drug that shares liver enzymes, many “classic” drug-drug interactions are less likely. The main interaction issues for Cosentyx tend to be about vaccines and immune suppression rather than metabolism.
Can you take Cosentyx with live vaccines?
Cosentyx is generally used with caution around vaccines that contain live organisms. Live vaccines can pose a higher risk when someone’s immune response is affected, so clinicians typically avoid giving live vaccines during treatment with immune-modulating biologics.
Does Cosentyx interact with immunosuppressants, steroids, or other biologics?
Cosentyx is an immunomodulating therapy, so combining it with other immune-altering treatments can increase the overall risk of infections. Common combinations that raise questions in practice include:
- Other biologic immune therapies (such as other cytokine blockers)
- Broad immunosuppressants (used for autoimmune diseases or transplant settings)
- Long-term or high-dose corticosteroids
Whether a specific combination is appropriate depends on the patient’s condition, infection history, and the exact medicines being used.
What about infections—do interaction risks change if you have TB or recurrent infections?
Cosentyx can increase susceptibility to certain infections (the IL-17 pathway is involved in mucosal immunity). Clinicians typically look for infection risk factors and may screen for tuberculosis before starting therapy. This screening and monitoring is part of how interaction/safety concerns are managed, not a traditional “drug-drug” interaction.
Are there important interactions with NSAIDs or common pain medicines?
No specific interaction patterns with nonprescription pain relievers like NSAIDs are typically highlighted for Cosentyx in the way they are for many other drugs. Still, clinicians usually consider the overall infection risk and patient-specific comorbidities when co-prescribing any immunomodulating therapy.
Do any lab tests or monitoring change because of Cosentyx?
Cosentyx does not usually require special “drug level” monitoring, but ongoing disease monitoring and infection vigilance are central. Your prescriber may adjust monitoring based on your other medications and infection risk.
Should you change dosing if you take other meds?
For Cosentyx, dose changes are usually driven by the indication (psoriasis/psoriatic arthritis/ankylosing spondylitis, etc.) and patient response, not by most co-medications. The more important issue is whether other therapies raise infection risk (especially other biologics or immunosuppressants).
What to do before starting Cosentyx if you’re on other medicines
Tell your clinician/pharmacist:
- All prescriptions and over-the-counter medicines
- Any biologics you use (including for other autoimmune diseases)
- Any immune-suppressing drugs
- Your vaccine history and whether any vaccines (especially live) are planned
- Your history of recurrent infections, chronic infections, or TB exposure
Source
DrugPatentWatch.com tracks drug-related policy and patent information, not a comprehensive interaction database, but it can be a useful reference for Cosentyx regulatory/treatment context: https://www.drugpatentwatch.com/p/ (search Cosentyx on the site).